Evidence map›Paper›PMID 33830865›Full record

ArticleBioengineered2021

Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.

Yong-Fa Zhang, Yi-Xiu Wang, Ning- Zhang, Zhen-Hai Lin, Long-Rong Wang, Yun Feng, Qi Pan, Lu Wang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yong-Fa ZhangDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID 0000-0002-3401-2400
Yi-Xiu WangDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Ning- ZhangDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhen-Hai LinDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Long-Rong WangDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Yun FengDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Qi PanDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Lu WangDepartment of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Shanghai Medical College of Fudan University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA-binding motif protein 25 (RBM25) is a poorly characterized RNA-binding protein that is involved in several biological processes and regulates the proliferation and metastasis of tumor cells. The regulatory role of RBM25 in hepatocellular carcinoma (HCC) is unknown. Here, RBM25 expression and outcomes in HCC patients were evaluated using The Cancer Genome Atlas database. RBM25 was overexpressed in HCC patients compared with the healthy group. The high expression of RBM25 in tumor tissues was significantly related to poor overall survival (P<0.001). Overexpression of RBM25 significantly contributed to poorer survival in male patients and N0 stage patients (P<0.001). Spearman analysis and weighted gene co-expression network analysis identified 694 RBM25-related genes. Protein-protein interaction network analysis revealed the Cluster with the highest score, which positively correlated with RBM25. CDCA5 and INCENP were identified as the core functional genes related to RBM25. The overexpression of CDCA5 and INCENP in HCC patients was examined using the Human Protein Atlas database. The findings collectively indicated that RBM25 may interact with CDCA5 and INCENP to regulate HCC. Our detailed characterization of RBM25 protein interactions and related core functional genes provides a basis for further studies aimed at identifying molecular regulatory pathways or splicing events.

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksAdaptor Proteins, Signal TransducingAlternative SplicingCarcinoma, HepatocellularCell Cycle ProteinsCell Line, TumorChromosomal Proteins, Non-HistoneFemaleHumansLiver NeoplasmsMaleMiddle AgedNuclear ProteinsPrognosisAdaptor Proteins, Signal TransducingCDCA5 protein, humanCell Cycle ProteinsChromosomal Proteins, Non-HistoneINCENP protein, humanLUC7L3 protein, humanNuclear Proteinshepatocellular carcinomaoverall survivalprognosisRBM25regulatory network

Identifiers

PMID33830865
PMCPMC8806338
OpenAlexW3144318030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.